Experimental Surgical Wound

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 2640 Experts worldwide ranked by ideXlab platform

Arthur O Tzianabos - One of the best experts on this subject based on the ideXlab platform.

  • hyaluronic acid binding peptides prevent Experimental staphylococcal Wound infection
    Antimicrobial Agents and Chemotherapy, 2006
    Co-Authors: Kathleen J Zaleski, Tadeusz Kolodka, Colette Cywesbentley, Rachel M Mcloughlin, Mary L Delaney, Bernard T Charlton, Wendy Johnson, Arthur O Tzianabos
    Abstract:

    Staphylococcus aureus is a major cause of Surgical Wound infections. The development of mechanisms of antimicrobial resistance by this and other bacterial pathogens has prompted the search for new approaches to treat infectious diseases. Hyaluronic acid binding peptides have been shown to modulate cellular trafficking during host responses and were assessed for their ability to treat and possibly prevent Experimental Surgical Wound infections caused by S. aureus. Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the Wound site and ameliorated the inflammatory host response associated with these infections. These data suggest a novel approach for the treatment and prophylaxis of staphylococcal Wound infections in the clinical setting.

Kathleen J Zaleski - One of the best experts on this subject based on the ideXlab platform.

  • hyaluronic acid binding peptides prevent Experimental staphylococcal Wound infection
    Antimicrobial Agents and Chemotherapy, 2006
    Co-Authors: Kathleen J Zaleski, Tadeusz Kolodka, Colette Cywesbentley, Rachel M Mcloughlin, Mary L Delaney, Bernard T Charlton, Wendy Johnson, Arthur O Tzianabos
    Abstract:

    Staphylococcus aureus is a major cause of Surgical Wound infections. The development of mechanisms of antimicrobial resistance by this and other bacterial pathogens has prompted the search for new approaches to treat infectious diseases. Hyaluronic acid binding peptides have been shown to modulate cellular trafficking during host responses and were assessed for their ability to treat and possibly prevent Experimental Surgical Wound infections caused by S. aureus. Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the Wound site and ameliorated the inflammatory host response associated with these infections. These data suggest a novel approach for the treatment and prophylaxis of staphylococcal Wound infections in the clinical setting.

Tadeusz Kolodka - One of the best experts on this subject based on the ideXlab platform.

  • hyaluronic acid binding peptides prevent Experimental staphylococcal Wound infection
    Antimicrobial Agents and Chemotherapy, 2006
    Co-Authors: Kathleen J Zaleski, Tadeusz Kolodka, Colette Cywesbentley, Rachel M Mcloughlin, Mary L Delaney, Bernard T Charlton, Wendy Johnson, Arthur O Tzianabos
    Abstract:

    Staphylococcus aureus is a major cause of Surgical Wound infections. The development of mechanisms of antimicrobial resistance by this and other bacterial pathogens has prompted the search for new approaches to treat infectious diseases. Hyaluronic acid binding peptides have been shown to modulate cellular trafficking during host responses and were assessed for their ability to treat and possibly prevent Experimental Surgical Wound infections caused by S. aureus. Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the Wound site and ameliorated the inflammatory host response associated with these infections. These data suggest a novel approach for the treatment and prophylaxis of staphylococcal Wound infections in the clinical setting.

Colette Cywesbentley - One of the best experts on this subject based on the ideXlab platform.

  • hyaluronic acid binding peptides prevent Experimental staphylococcal Wound infection
    Antimicrobial Agents and Chemotherapy, 2006
    Co-Authors: Kathleen J Zaleski, Tadeusz Kolodka, Colette Cywesbentley, Rachel M Mcloughlin, Mary L Delaney, Bernard T Charlton, Wendy Johnson, Arthur O Tzianabos
    Abstract:

    Staphylococcus aureus is a major cause of Surgical Wound infections. The development of mechanisms of antimicrobial resistance by this and other bacterial pathogens has prompted the search for new approaches to treat infectious diseases. Hyaluronic acid binding peptides have been shown to modulate cellular trafficking during host responses and were assessed for their ability to treat and possibly prevent Experimental Surgical Wound infections caused by S. aureus. Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the Wound site and ameliorated the inflammatory host response associated with these infections. These data suggest a novel approach for the treatment and prophylaxis of staphylococcal Wound infections in the clinical setting.

Rachel M Mcloughlin - One of the best experts on this subject based on the ideXlab platform.

  • hyaluronic acid binding peptides prevent Experimental staphylococcal Wound infection
    Antimicrobial Agents and Chemotherapy, 2006
    Co-Authors: Kathleen J Zaleski, Tadeusz Kolodka, Colette Cywesbentley, Rachel M Mcloughlin, Mary L Delaney, Bernard T Charlton, Wendy Johnson, Arthur O Tzianabos
    Abstract:

    Staphylococcus aureus is a major cause of Surgical Wound infections. The development of mechanisms of antimicrobial resistance by this and other bacterial pathogens has prompted the search for new approaches to treat infectious diseases. Hyaluronic acid binding peptides have been shown to modulate cellular trafficking during host responses and were assessed for their ability to treat and possibly prevent Experimental Surgical Wound infections caused by S. aureus. Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the Wound site and ameliorated the inflammatory host response associated with these infections. These data suggest a novel approach for the treatment and prophylaxis of staphylococcal Wound infections in the clinical setting.